Chromocell Therapeutics (CHRO) SEC Filings & 10K Form

$1.83
+0.06 (+3.39%)
(As of 05/10/2024 ET)

Recent Chromocell Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2024
3:48 PM
Chromocell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/12/2024
6:22 PM
Chromocell Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/09/2024
7:30 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form NT 10-K
03/21/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
4:10 PM
Chromocell Therapeutics (Subject)
Motif Pharmaceuticals Ltd. (Filed by)
Form SC 13G
03/01/2024
4:13 PM
AME Equities LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:16 PM
Aperture Healthcare Ventures Ltd. (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:19 PM
Benuvia Operations, LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
02/26/2024
5:36 PM
Chromocell Therapeutics (Subject)
Friedberg Ezra M (Filed by)
Form SC 13D
02/23/2024
4:12 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:15 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:17 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:28 PM
Chromocell Therapeutics (Filer)
Form 424B4
02/20/2024
4:30 PM
Chromocell Therapeutics (Filer)
Form 424B4
02/15/2024
8:56 PM
Chromocell Therapeutics (Filer)
Form POS EX
02/15/2024
7:33 PM
Aperture Healthcare Ventures Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:36 PM
Chromocell Therapeutics (Issuer)
Motif Pharmaceuticals Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:38 PM
Boswell Prayer Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:25 PM
AME Equities LLC (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:31 PM
Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:02 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:06 PM
Balmoral Financial Group LLC (Reporting)
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:10 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:12 PM
Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:14 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
10:46 AM
Chromocell Therapeutics (Filer)
Form CERT
02/15/2024
10:35 AM
Chromocell Therapeutics (Filer)
Form 8-A12B
02/14/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
02/12/2024
7:09 AM
Chromocell Therapeutics (Subject)
Form FWP
02/12/2024
7:02 AM
Chromocell Therapeutics (Filer)
Form S-1/A
02/06/2024
7:40 PM
Chromocell Therapeutics (Filer)
Form S-1/A
02/06/2024
7:43 PM
Chromocell Therapeutics (Subject)
Form FWP
01/16/2024
4:28 PM
Chromocell Therapeutics (Filer)
Form S-1/A
11/07/2023
8:23 PM
Chromocell Therapeutics (Subject)
Form FWP
10/25/2023
3:39 PM
Chromocell Therapeutics (Filer)
Form S-1/A
10/13/2023
6:34 PM
Chromocell Therapeutics (Filer)
Form S-1/A
10/16/2023
5:00 AM
Chromocell Therapeutics (Subject)
Form FWP
09/01/2023
3:59 PM
Chromocell Therapeutics (Filer)
Form S-1/A
07/19/2023
8:15 PM
Chromocell Therapeutics (Filer)
Form S-1/A
Collapse of the Petrodollar (Ad)

The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.

In answer to this issue, we have released a Special Report to the public.
06/30/2023
1:13 PM
Chromocell Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:CHRO) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners